Articles

ECB ready to start cutting interest rates, chief economist says

The European Central Bank will likely cut interest rates from historic highs at its meeting on June 6th and, and in an interview with the Financial Times on Monday, its chief economist, Philip Lane, brushed off fears that doing so before the U.S. Federal Reserve could backfire.

China semiconductor stocks rally on reports of $48 billion chip fund

The third phase of the China Integrated Circuit Industry Investment Fund has reportedly doubled what was raised in 2014 and 2019,

German Ifo business sentiment index idles as services sector falters

Post Content

Shares of China Evergrande’s EV unit soar on potential investor support

China Evergrande New Energy Vehicle shares jumped 92% on Monday after the EV startup said liquidators were in talks to sell a 29% stake in the unit to an unnamed buyer.

Musk’s xAI raises $6 billion in fresh funding from Fidelity, Sequoia Capital and others

Elon Musk’s xAI company has raised $6 billion in a series B round of funding from investors including Fidelity Management & Research Co. and venture-capital firm Sequoia Capital.

Wall Street economists expect ‘friendly’ U.S. inflation data this Friday

Expectations about the future path of Federal Reserve interest-rate policy has been on a roller coaster this year and the next potential swoon could come Friday with the release of the Fed’s preferred inflation measure of consumer inflation.

Stocks are making Americans feel richer — and the Fed’s inflation fight harder

With an estimated 62% of U.S. adults owning stocks, it becomes increasingly difficult to see how consumer demand can taper off by enough to bring down inflation.

Some buzzy AI names highlight this week’s earnings slate — along with Costco

Dell and Marvell will offer glimpses into AI spending, while Costco and Gap are among big retail names due to report.

Blackstone CEO Schwarzman re-embraces Trump for 2024 elections

Blackstone chairman and CEO, Stephen Schwarzman, will support Donald Trump in the November U.S. presidential elections as a “vote for change”, giving Trump access to a network of Republican party donors, after earlier expressing the need for new Republican party leadership, Axios has reported.

Ozempic cuts kidney-disease risks, research finds

Novo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, according to new research published Friday.

New Alzheimer’s drugs could be developed from this appetite-suppressing hormone

Promising new research suggests amino acids found naturally in the human body could be turned into a drug to fight dementia

The Dow’s shaky week: Will Fed rate jitters spark bout of summertime blues?

Nervous types may worry over whether a renewed focus on when or whether rate cuts will arrive along with lofty valuations could set the stage for some summertime blues.
1 967 968 969 970 971 2,158